{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:41:10Z","timestamp":1785796870411,"version":"3.56.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,12,17]],"date-time":"2015-12-17T00:00:00Z","timestamp":1450310400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s13277-015-4581-x","type":"journal-article","created":{"date-parts":[[2015,12,17]],"date-time":"2015-12-17T02:49:04Z","timestamp":1450320544000},"page":"7461-7471","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1"],"prefix":"10.1007","volume":"37","author":[{"given":"Chen","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. James","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoguang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,17]]},"reference":[{"key":"4581_CR1","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000360200","volume":"132","author":"Y Ofran","year":"2014","unstructured":"Ofran Y, Rowe JM. Acute myeloid leukemia in adolescents and young adults: challenging aspects. Acta Haematol. 2014;132:292\u20137.","journal-title":"Acta Haematol"},{"key":"4581_CR2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.canlet.2012.07.014","volume":"338","author":"C Lutz","year":"2013","unstructured":"Lutz C, Hoang VT, Buss E, Ho AD. Identifying leukemia stem cells\u2014is it feasible and does it matter? Cancer Lett. 2013;338:10\u20134.","journal-title":"Cancer Lett"},{"key":"4581_CR3","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/biot.201100350","volume":"7","author":"VT Hoang","year":"2012","unstructured":"Hoang VT, Zepeda-Moreno A, Ho AD. Identification of leukemia stem cells in acute myeloid leukemia and their clinical relevance. Biotechnol J. 2012;7:779\u201388.","journal-title":"Biotechnol J"},{"key":"4581_CR4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.canlet.2011.12.017","volume":"318","author":"M She","year":"2012","unstructured":"She M, Niu X, Chen X, Li J, Zhou M, He Y, et al. Resistance of leukemic stem-like cells in AML cell line KG1a to natural killer cell-mediated cytotoxicity. Cancer Lett. 2012;318:173\u20139.","journal-title":"Cancer Lett"},{"key":"4581_CR5","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/ijc.26318","volume":"129","author":"EC Buss","year":"2011","unstructured":"Buss EC, Ho AD. Leukemia stem cells. Int J Cancer. 2011;129:2328\u201336.","journal-title":"Int J Cancer"},{"key":"4581_CR6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2174\/156800911793743655","volume":"11","author":"P Valent","year":"2011","unstructured":"Valent P. Targeting of leukemia-initiating cells to develop curative drug therapies: straightforward but nontrivial concept. Curr Cancer Drug Targets. 2011;11:56\u201371.","journal-title":"Curr Cancer Drug Targets"},{"key":"4581_CR7","doi-asserted-by":"crossref","first-page":"17ra9","DOI":"10.1126\/scitranslmed.3000349","volume":"2","author":"Y Saito","year":"2010","unstructured":"Saito Y, Kitamura H, Hijikata A, Tomizawa-Murasawa M, Tanaka S, Takagi S, et al. Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells. Sci Transl Med. 2010;2:17ra9.","journal-title":"Sci Transl Med"},{"key":"4581_CR8","doi-asserted-by":"crossref","first-page":"e78453","DOI":"10.1371\/journal.pone.0078453","volume":"8","author":"SM Kornblau","year":"2013","unstructured":"Kornblau SM, Qutub A, Yao H, York H, Qiu YH, Graber D, et al. Proteomic profiling identifies distinct protein patterns in acute myelogenous leukemia CD34+CD38- stem-like cells. PLoS One. 2013;8:e78453.","journal-title":"PLoS One"},{"key":"4581_CR9","doi-asserted-by":"crossref","first-page":"e78897","DOI":"10.1371\/journal.pone.0078897","volume":"8","author":"GJ Schuurhuis","year":"2013","unstructured":"Schuurhuis GJ, Meel MH, Wouters F, Min LA, Terwijn M, de Jonge NA, et al. Normal hematopoietic stem cells within the AML bone marrow have a distinct and higher ALDH activity level than co-existing leukemic stem cells. PLoS One. 2013;8:e78897.","journal-title":"PLoS One"},{"key":"4581_CR10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/978-1-62703-508-8_19","volume":"1035","author":"VT Hoang","year":"2013","unstructured":"Hoang VT, Hoffmann I, Borowski K, Zepeda-Moreno A, Ran D, Buss EC, et al. Identification and separation of normal hematopoietic stem cells and leukemia stem cells from patients with acute myeloid leukemia. Methods Mol Biol. 2013;1035:217\u201330.","journal-title":"Methods Mol Biol"},{"key":"4581_CR11","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1182\/blood-2009-05-222836","volume":"115","author":"F Nakahara","year":"2010","unstructured":"Nakahara F, Sakata-Yanagimoto M, Komeno Y, Kato N, Uchida T, Haraguchi K, et al. Hes1 immortalizes committed progenitors and plays a role in blast crisis transition in chronic myelogenous leukemia. Blood. 2010;115:2872\u201381.","journal-title":"Blood"},{"key":"4581_CR12","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4161\/cc.23160","volume":"12","author":"C Tian","year":"2013","unstructured":"Tian C, Zheng G, Cao Z, Li Q, Ju Z, Wang J, et al. Hes1 mediates the different responses of hematopoietic stem and progenitor cells to T cell leukemic environment. Cell Cycle. 2013;12:322\u201331.","journal-title":"Cell Cycle"},{"key":"4581_CR13","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/leu.2014.281","volume":"29","author":"T Kato","year":"2015","unstructured":"Kato T, Sakata-Yanagimoto M, Nishikii H, Ueno M, Miyake Y, Yokoyama Y, et al. Hes1 suppresses acute myeloid leukemia development through FLT3 repression. Leukemia. 2015;29:576\u201385.","journal-title":"Leukemia"},{"key":"4581_CR14","doi-asserted-by":"crossref","first-page":"899","DOI":"10.2147\/OTT.S83511","volume":"8","author":"C Tian","year":"2015","unstructured":"Tian C, Tang Y, Wang T, Yu Y, Wang X, Wang Y, et al. HES1 is an independent prognostic factor for acute myeloid leukemia. Onco Targets Ther. 2015;8:899\u2013904.","journal-title":"Onco Targets Ther"},{"key":"4581_CR15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/nass\/48.1.213","volume":"48","author":"H Kimura","year":"2004","unstructured":"Kimura H, Kawasaki H, Taira K. Mouse microRNA-23b regulates expression of Hes1 gene in P19 cells. Nucleic Acids Symp Ser (Oxf). 2004;48:213\u20134.","journal-title":"Nucleic Acids Symp Ser (Oxf)"},{"key":"4581_CR16","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/nature01730","volume":"423","author":"H Kawasaki","year":"2003","unstructured":"Kawasaki H, Taira K. Hes1 is a target of microRNA-23 during retinoic-acid-induced neuronal differentiation of NT2 cells. Nature. 2003;423:838\u201342.","journal-title":"Nature"},{"key":"4581_CR17","doi-asserted-by":"crossref","first-page":"e4998","DOI":"10.1371\/journal.pone.0004998","volume":"4","author":"L Garzia","year":"2009","unstructured":"Garzia L, Andolfo I, Cusanelli E, Marino N, Petrosino G, De Martino D, et al. MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma. PLoS One. 2009;4:e4998.","journal-title":"PLoS One"},{"key":"4581_CR18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.celrep.2012.05.017","volume":"2","author":"B Bonev","year":"2012","unstructured":"Bonev B, Stanley P, Papalopulu N. MicroRNA-9 modulates Hes1 ultradian oscillations by forming a double-negative feedback loop. Cell Rep. 2012;2:10\u20138.","journal-title":"Cell Rep"},{"key":"4581_CR19","doi-asserted-by":"crossref","first-page":"473","DOI":"10.4252\/wjsc.v6.i4.473","volume":"6","author":"J Zhou","year":"2014","unstructured":"Zhou J, Chng WJ. Identification and targeting leukemia stem cells: the path to the cure for acute myeloid leukemia. World J Stem Cells. 2014;6:473\u201384.","journal-title":"World J Stem Cells"},{"key":"4581_CR20","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1084\/jem.20140131","volume":"211","author":"AL Boyd","year":"2014","unstructured":"Boyd AL, Campbell CJ, Hopkins CI, Fiebig-Comyn A, Russell J, Ulemek J, et al. Niche displacement of human leukemic stem cells uniquely allows their competitive replacement with healthy HSPCs. J Exp Med. 2014;211:1925\u201335.","journal-title":"J Exp Med"},{"key":"4581_CR21","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.1073\/pnas.1302352110","volume":"110","author":"H Zhang","year":"2013","unstructured":"Zhang H, Mi JQ, Fang H, Wang Z, Wang C, Wu L, et al. Preferential eradication of acute myelogenous leukemia stem cells by fenretinide. Proc Natl Acad Sci USA. 2013;110:5606\u201311.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4581_CR22","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1158\/0008-5472.CAN-13-1733","volume":"74","author":"DC Leeuw de","year":"2014","unstructured":"de Leeuw DC, Denkers F, Olthof MC, Rutten AP, Pouwels W, Schuurhuis GJ, et al. Attenuation of microRNA-126 expression that drives CD34+CD38- stem\/progenitor cells in acute myeloid leukemia leads to tumor eradication. Cancer Res. 2014;74:2094\u2013105.","journal-title":"Cancer Res"},{"key":"4581_CR23","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s00277-015-2413-0","volume":"94","author":"C Tian","year":"2015","unstructured":"Tian C, Yu Y, Jia Y, Zhu L, Zhang Y. HES1 activation suppresses proliferation of leukemia cells in acute myeloid leukemia. Ann Hematol. 2015;94:1477\u201383.","journal-title":"Ann Hematol"},{"key":"4581_CR24","doi-asserted-by":"crossref","first-page":"11511","DOI":"10.1073\/pnas.1310144110","volume":"110","author":"P Chen","year":"2013","unstructured":"Chen P, Price C, Li Z, Li Y, Cao D, Wiley A, et al. miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia-rearranged leukemia. Proc Natl Acad Sci U S A. 2013;110:11511\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4581_CR25","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/leu.2013.357","volume":"28","author":"S Emmrich","year":"2014","unstructured":"Emmrich S, Katsman-Kuipers JE, Henke K, Khatib ME, Jammal R, Engeland F, et al. miR-9 is a tumor suppressor in pediatric AML with t(8;21). Leukemia. 2014;28:1022\u201332.","journal-title":"Leukemia"},{"key":"4581_CR26","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/leu.2014.333","volume":"29","author":"MK Chuang","year":"2015","unstructured":"Chuang MK, Chiu YC, Chou WC, Hou HA, Chuang EY, Tien HF. A 3-microRNA scoring system for prognostication in de novo acute myeloid leukemia patients. Leukemia. 2015;29:1051\u20139.","journal-title":"Leukemia"},{"key":"4581_CR27","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/jcp.24876","volume":"230","author":"M Cattaneo","year":"2014","unstructured":"Cattaneo M, Pelosi E, Castelli G, Cerio AM, DAngio A, Porretti L, et al. A miRNA signature in human cord blood stem and progenitor cells as potential biomarker of specific acute myeloid leukemia subtypes. J Cell Physiol. 2014;230:1770\u201380.","journal-title":"J Cell Physiol"},{"key":"4581_CR28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ccr.2013.05.004","volume":"24","author":"PG Miller","year":"2013","unstructured":"Miller PG, Al-Shahrour F, Hartwell KA, Chu LP, J\u00e4r\u00e5s M, Puram RV, et al. In vivo RNAi screening identifies a leukemia-specific dependence on integrin beta 3 signaling. Cancer Cell. 2013;24:45\u201358.","journal-title":"Cancer Cell"},{"key":"4581_CR29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12929-015-0113-7","volume":"22","author":"SH Chan","year":"2015","unstructured":"Chan SH, Wang LH. Regulation of cancer metastasis by microRNAs. J Biomed Sci. 2015;22:9.","journal-title":"J Biomed Sci"},{"key":"4581_CR30","doi-asserted-by":"crossref","unstructured":"Testa U, Pelosi E. MicroRNAs expressed in hematopoietic stem\/progenitor cells are deregulated in acute myeloid leukemias. Leuk Lymphoma 2015;56:1466\u201374.","DOI":"10.3109\/10428194.2014.955019"},{"key":"4581_CR31","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1084\/jem.20121527","volume":"210","author":"S Kannan","year":"2013","unstructured":"Kannan S, Sutphin R, Hall M, Golfman L, Fang W, Nolo R, et al. Notch activation inhibits AML growth and survival: a potential therapeutic approach. J Exp Med. 2013;210:321\u201337.","journal-title":"J Exp Med"},{"key":"4581_CR32","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ccr.2013.06.002","volume":"24","author":"F Vaillant","year":"2013","unstructured":"Vaillant F, Merino F, Lee L, Breslin K, Pal B, Ritchie M, et al. Targeting BCL-2 with the BH3 mimetic ABT-199 in estrogen receptor-positive breast cancer. Cancer Cell. 2013;24:120\u20139.","journal-title":"Cancer Cell"},{"key":"4581_CR33","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.ccell.2015.04.010","volume":"27","author":"B Han","year":"2015","unstructured":"Han B, Park D, Li R, Xie M, Owonikoko T, Zhang G, et al. Small-molecule Bcl2 BH4 antagonist for lung cancer therapy. Cancer Cell. 2015;27:852\u201363.","journal-title":"Cancer Cell"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4581-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-015-4581-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4581-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4581-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T11:43:50Z","timestamp":1559475830000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-015-4581-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,17]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["4581"],"URL":"https:\/\/doi.org\/10.1007\/s13277-015-4581-x","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,17]]}}}